Structures by: Oliver A. G.
Total: 342
C31.75H31FeN3O16.75
C31.75H31FeN3O16.75
Crystal Growth & Design (2012) 12, 5 2684
a=9.8454(17)Å b=32.640(6)Å c=11.319(2)Å
α=90.00° β=111.469(4)° γ=90.00°
C26H24FeN4O14.5
C26H24FeN4O14.5
Crystal Growth & Design (2012) 12, 5 2684
a=10.1969(10)Å b=11.0817(11)Å c=13.9784(15)Å
α=95.445(2)° β=105.167(2)° γ=113.937(2)°
C46.6H44BaFe2N4O31.4
C46.6H44BaFe2N4O31.4
Crystal Growth & Design (2012) 12, 5 2684
a=10.1267(3)Å b=41.4321(12)Å c=24.9603(7)Å
α=90.00° β=92.4170(10)° γ=90.00°
C36H36FeN5O5,0.9(CHCl3)
C36H36FeN5O5,0.9(CHCl3)
Inorganic chemistry (2014) 53, 7 3763
a=10.6098(6)Å b=11.0454(6)Å c=15.5814(9)Å
α=101.428(3)° β=97.149(3)° γ=94.792(3)°
Er(CzTiPr)[N(SiMe3)2]2
C40H72ErN11Si4,2(C7H8)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 43 15487-15496
a=11.1978(5)Å b=15.7727(8)Å c=19.3549(9)Å
α=108.997(2)° β=104.761(2)° γ=97.811(2)°
C43H37CuN5OP2,ClO4,C2H6O
C43H37CuN5OP2,ClO4,C2H6O
Dalton Trans. (2017)
a=9.5788(11)Å b=13.3745(16)Å c=17.068(2)Å
α=105.687(3)° β=93.029(3)° γ=101.325(3)°
C58H50CuN6O0.34P4,ClO4
C58H50CuN6O0.34P4,ClO4
Dalton Trans. (2017)
a=19.6651(16)Å b=12.1590(11)Å c=22.774(2)Å
α=90.00° β=104.059(2)° γ=90.00°
C36H36N4O4,C2H6OS
C36H36N4O4,C2H6OS
The Journal of organic chemistry (2019) 84, 7 4050-4057
a=9.4746(4)Å b=13.2356(6)Å c=14.2481(7)Å
α=79.948(3)° β=85.978(3)° γ=84.632(3)°
2(C36H36N4O4),2(C16H36N),2(C2H3O2),2(CHCl3),C4H10O
2(C36H36N4O4),2(C16H36N),2(C2H3O2),2(CHCl3),C4H10O
The Journal of organic chemistry (2019) 84, 7 4050-4057
a=25.208(2)Å b=16.8924(13)Å c=26.912(2)Å
α=90° β=90° γ=90°
2-[[[4-[4-[(2-Diethylamino-5-nitropyrimidin-4-yl)amino] phenoxy]phenyl]sulfonyl]methyl]thiirane
C23H25N5O5S2
The Journal of organic chemistry (2015) 80, 15 7757-7763
a=6.2113(11)Å b=12.992(2)Å c=16.159(3)Å
α=68.490(3)° β=87.806(3)° γ=83.013(4)°
C36H34GdN7O11
C36H34GdN7O11
Journal of the American Chemical Society (2007) 129, 11153-11160
a=12.3590(18)Å b=26.307(4)Å c=10.5933(15)Å
α=90.00° β=96.343(3)° γ=90.00°
C36H34HoN7O11
C36H34HoN7O11
Journal of the American Chemical Society (2007) 129, 11153-11160
a=12.345(2)Å b=26.153(4)Å c=10.5557(17)Å
α=90.00° β=96.306(3)° γ=90.00°
C17H17N5O6
C17H17N5O6
Journal of the American Chemical Society (2013) 135, 3539-3549
a=10.7900(4)Å b=10.1646(4)Å c=16.7717(7)Å
α=90.00° β=105.078(2)° γ=90.00°
[Co(TPP)(NO)]
C44H28CoN5O
Inorganic Chemistry (2010) 49, 6552-6557
a=13.3518(3)Å b=13.3518(3)Å c=9.6444(3)Å
α=90.00° β=90.00° γ=90.00°
C24H16O30P8U2,C16H40N2
C24H16O30P8U2,C16H40N2
Crystal Growth & Design (2011) 11, 5 1966
a=16.651(4)Å b=20.376(4)Å c=8.7419(19)Å
α=90.00° β=90.00° γ=90.00°
C24H16F2O38P8U6,C8H24N2,O
C24H16F2O38P8U6,C8H24N2,O
Crystal Growth & Design (2011) 11, 5 1966
a=11.2370(5)Å b=20.8524(9)Å c=14.6189(7)Å
α=90.00° β=104.9970(10)° γ=90.00°
C3H6F2O6Pb2S2
C3H6F2O6Pb2S2
Crystal Growth & Design (2010) 10, 2 823
a=24.160(3)Å b=4.6101(6)Å c=8.8375(11)Å
α=90.00° β=102.420(2)° γ=90.00°
C84H48Ni8O118.72P16U12
C84H48Ni8O118.72P16U12
Inorganic Chemistry (2012) 51, 4885-4887
a=36.380(3)Å b=36.380(3)Å c=36.380(3)Å
α=90.00° β=90.00° γ=90.00°
C18H33N2O2S2Rh
C18H33N2O2S2Rh
Inorganic Chemistry (2001) 40, 5299-5301
a=9.7213(1)Å b=10.9246(2)Å c=19.3747(4)Å
α=90° β=90° γ=90°
[K-crypt]3[Ge9Tl].2py
3(C18H36KN2O6),2(C5H5N),Ge9Tl
Inorganic Chemistry (2011) 50, 2373-2377
a=21.9176(4)Å b=21.9176(4)Å c=36.9948(8)Å
α=90.00° β=90.00° γ=90.00°
(K-crypt)6(Ni@Sn9)2(en)3(tol)
6(C18H36N2O6K),2(NiSn9),3(C2H8N2),C7H8
Inorganic Chemistry (2011) 50, 2373-2377
a=28.0012(14)Å b=23.3701(10)Å c=27.6515(14)Å
α=90.00° β=93.561(3)° γ=90.00°
C112H232K6N16Ni2O36Sn18Tl0.88
C112H232K6N16Ni2O36Sn18Tl0.88
Inorganic Chemistry (2011) 50, 2373-2377
a=28.2574(11)Å b=23.4554(9)Å c=27.7372(10)Å
α=90.00° β=93.2360(10)° γ=90.00°
C28H30Cs3O5
C28H30Cs3O5
Inorganic Chemistry (2012) 51, 1020-1027
a=7.8905(3)Å b=19.0010(7)Å c=21.1957(9)Å
α=90.00° β=90.00° γ=90.00°
C28H35K3O5
C28H35K3O5
Inorganic Chemistry (2012) 51, 1020-1027
a=19.2016(12)Å b=20.4584(12)Å c=7.2704(5)Å
α=90.00° β=90.113(4)° γ=90.00°
C29H30O5Rb3
C29H30O5Rb3
Inorganic Chemistry (2012) 51, 1020-1027
a=7.4579(3)Å b=19.2403(6)Å c=21.0434(6)Å
α=90.00° β=90.00° γ=90.00°
C37H46Cl6FeN4OSb0.5
C37H46Cl6FeN4OSb0.5
Inorganic Chemistry (2011) 50, 9114-9121
a=10.333(2)Å b=12.555(3)Å c=15.849(3)Å
α=83.64(3)° β=77.53(3)° γ=87.19(3)°
C28H43ILiN6Ta
C28H43ILiN6Ta
Organometallics (2016) 35, 20 3452
a=10.4676(5)Å b=11.0982(5)Å c=15.7331(8)Å
α=96.432(2)° β=92.191(2)° γ=117.377(2)°
ACD-2
C15H14Cl2N2OPd,CHCl3
Organometallics (2013) 32, 7 2257
a=9.7515(7)Å b=11.4741(8)Å c=17.4586(14)Å
α=90° β=90° γ=90°
C13H18Cl2N2OPd,CH2Cl2
C13H18Cl2N2OPd,CH2Cl2
Organometallics (2013) 32, 7 2257
a=9.4035(4)Å b=11.5964(4)Å c=17.0774(6)Å
α=90.00° β=90.00° γ=90.00°
PdNeoBoxH
C28H34F6N4O12Pd2S2
Organometallics (2013) 32, 7 2257
a=13.9076(8)Å b=23.8618(13)Å c=22.5455(12)Å
α=90° β=90° γ=90°
TH-6-116
C24H38IN8Ta
Organometallics (2014) 33, 4 952
a=10.6851(12)Å b=10.9572(12)Å c=24.299(3)Å
α=89.884(1)° β=84.039(1)° γ=86.730(1)°
C25.83H39.49I1.08N5.92Ta
C25.83H39.49I1.08N5.92Ta
Organometallics (2014) 33, 4 952
a=14.3009(6)Å b=14.0597(6)Å c=14.6315(6)Å
α=90° β=95.564(2)° γ=90°
C26H42IN6Ta
C26H42IN6Ta
Organometallics (2014) 33, 4 952
a=14.3180(5)Å b=14.0456(4)Å c=14.6775(4)Å
α=90.00° β=95.1710(10)° γ=90.00°
C25.91H39.74I1.04N5.96Ta
C25.91H39.74I1.04N5.96Ta
Organometallics (2014) 33, 4 952
a=14.3127(11)Å b=14.0503(11)Å c=14.6499(12)Å
α=90° β=95.453(3)° γ=90°
3(C18H36KN2O3),Bi7,2(C5H5N)
3(C18H36KN2O3),Bi7,2(C5H5N)
Inorganic chemistry (2015) 54, 3 872-875
a=13.8739(13)Å b=24.878(2)Å c=26.401(2)Å
α=90° β=96.353(4)° γ=90°
C24H34Ag2N4O10
C24H34Ag2N4O10
To be published in Crystal Growth and Design
a=11.464(3)Å b=18.299(5)Å c=14.010(4)Å
α=90° β=102.275(4)° γ=90°
N-Benzyl-3,7-dimethylimidazo[1,2-a]pyridine-2-carboxamide
C17H17N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=7.9379(3)Å b=19.6844(9)Å c=9.5568(4)Å
α=90.° β=100.934(2)° γ=90.°
N-Benzyl-7-methyl-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide
C15H14N4O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=9.772(3)Å b=5.8461(19)Å c=22.078(7)Å
α=90.° β=91.411(6)° γ=90.°
N-Benzyl-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
C15H15N5O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=20.3189(11)Å b=10.8268(5)Å c=15.6023(9)Å
α=90.° β=129.107(3)° γ=90.°
N-Benzyl-6-methyl-2H-indazole-3-carboxamide
C16H15N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=5.9164(2)Å b=13.0740(3)Å c=18.5711(5)Å
α=109.4990(10)° β=93.229(2)° γ=94.402(2)°
N-Benzyl-2,6-dimethyl-1H-indole-3-carboxamide
C18H18N2O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=4.7830(3)Å b=25.5753(15)Å c=11.9469(7)Å
α=90.° β=98.639(3)° γ=90.°
N-Benzyl-2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide (1)
C17H17N3O
Bioorganic & Medicinal Chemistry Letters (2014) 24, 3493-3498
a=4.8686(4)Å b=15.1351(13)Å c=19.0283(18)Å
α=94.372(5)° β=93.841(6)° γ=93.639(5)°